Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 5/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31660077 | 1.00 | CYP11B2 (0.33) | CYP11B2CYP11B1ARKDM4EPDK1 | |
| SCHEMBL25153188 | 0.89 | KDM4E (0.35) | KDM4EKDR | |
| SCHEMBL30370412 | 0.89 | KDM4E (0.35) | KDM4EKDR | |
| SCHEMBL25147763 | 0.85 | PDK2 (0.35) | CYP11B2CYP11B1ARPDK1PDK2 | |
| SCHEMBL31659690 | 0.85 | PDK2 (0.35) | CYP11B2CYP11B1ARPDK1PDK2 | |
| SCHEMBL25147750 | 0.85 | SMO (0.34) | CYP11B2CYP11B1ARHDAC6KDR | |
| SCHEMBL31659593 | 0.85 | SMO (0.34) | CYP11B2CYP11B1ARHDAC6KDR | |
| SCHEMBL31659721 | 0.81 | GRIN2D (0.32) | KDM4E | |
| SCHEMBL25148366 | 0.81 | GRIN2D (0.32) | KDM4E | |
| SCHEMBL25147753 | 0.80 | KDM4E (0.33) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064585-A1 | 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS | VANDERBILT UNIVERSITY (US) | 2023-04-20 | — | — | WO | disclosed |